Personal information

Other IDs

Scopus Author ID: 36131603200

Activities

Collapse all

Employment (1)

Slovak Medical University: Bratislava, Slovakia, SK

2002-04-01 to present | Head (Neurology )
Employment
Source: Self-asserted source
Georgi Krastev

Works (9)

IgG-NR2B—A Potentially Valuable Biomarker in the Management of Refractory Anti-NMDAR Encephalitis

International Journal of Molecular Sciences
2025-01-09 | Journal article
DOI: 10.3390/ijms26020513
Contributors: Zuzana Števková; Georgi Krastev; Miroslav Mako; Zuzana Čierna
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Analysis of Safety and Efficacy of the Early Initiation of Antithrombotic Secondary Prevention in Patients Treated with Intravenous Thrombolysis for Acute Ischemic Stroke

Journal of Clinical Medicine
2024-05-05 | Journal article
DOI: 10.3390/jcm13092710
Contributors: Georgi Krastev; Miroslav Mako; Zuzana Števková; Romana Havranová; Kristína Andrášiková
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Low Lymphocyte-to-Monocyte Ratio as a Possible Predictor of an Unfavourable Clinical Outcome in Patients with Acute Ischemic Stroke after Mechanical Thrombectomy

Stroke Research and Treatment
2022-12-10 | Journal article
DOI: 10.1155/2022/9243080
Contributors: Katarína Pinčáková; Georgi Krastev; Jozef Haring; Miroslav Mako; Viktória Mikulášková; Vladimír Bošák; Domenico Maria Mezzapesa
Source: check_circle
Crossref

An injectable implant to stimulate the sphenopalatine ganglion for treatment of acute ischaemic stroke up to 24 h from onset (ImpACT-24B): an international, randomised, double-blind, sham-controlled, pivotal trial

The Lancet
2019 | Journal article
DOI: 10.1016/S0140-6736(19)31192-4
EID:

2-s2.0-85069496394
Contributors: Bornstein, N.M.; Saver, J.L.; Diener, H.C.; Gorelick, P.B.; Shuaib, A.; Solberg, Y.; Thackeray, L.; Savic, M.; Janelidze, T.; Zarqua, N. et al.
Source: Self-asserted source
Georgi Krastev via Scopus - Elsevier

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

The Lancet
2018 | Journal article
DOI: 10.1016/S0140-6736(18)30475-6
EID:

2-s2.0-85044304126
Contributors: Kappos, L.; Bar-Or, A.; Cree, B.A.C.; Fox, R.J.; Giovannoni, G.; Gold, R.; Vermersch, P.; Arnold, D.L.; Arnould, S.; Scherz, T. et al.
Source: Self-asserted source
Georgi Krastev via Scopus - Elsevier

Comparison of fatal or irreversible events with extended-duration betrixaban versus standard dose enoxaparin in acutely Ill medical patients: An APEX trial substudy

Journal of the American Heart Association
2017 | Journal article
DOI: 10.1161/JAHA.117.006015
EID:

2-s2.0-85025451180
Contributors: Gibson, C.M.; Korjian, S.; Chi, G.; Daaboul, Y.; Jain, P.; Arbetter, D.; Goldhaber, S.Z.; Hull, R.; Hernandez, A.F.; Lopes, R.D. et al.
Source: Self-asserted source
Georgi Krastev via Scopus - Elsevier

Extended thromboprophylaxis with betrixaban in acutely ill medical patients

New England Journal of Medicine
2016 | Journal article
DOI: 10.1056/NEJMoa1601747
EID:

2-s2.0-84981709094
Contributors: Cohen, A.T.; Harrington, R.A.; Goldhaber, S.Z.; Hull, R.D.; Wiens, B.L.; Gold, A.; Hernandez, A.F.; Gibson, C.M.; Bello, F.; Ferrari, A.E. et al.
Source: Self-asserted source
Georgi Krastev via Scopus - Elsevier

A unique case of coincidence of early onset Parkinson's disease and multiple sclerosis

Movement Disorders
2007 | Journal article
DOI: 10.1002/mds.21642
EID:

2-s2.0-38049085327
Contributors: Valkovic, P.; Krastev, G.; Mako, M.; Leitner, P.; Gasser, T.
Source: Self-asserted source
Georgi Krastev via Scopus - Elsevier

Abnormalities of Haemocoagulation in the Acute Stage of Ischaemic Cerebrovascular Attack,Hemokoagulačné abnormity v akútnej fáze ischemickej cievnej mozgovej príhody

Ceska a Slovenska Neurologie a Neurochirurgie
2000 | Journal article
EID:

2-s2.0-0346638578
Contributors: Timárová, G.; Kukumberg, P.; Skraková, A.; Šabo, L.; Gazdíková, K.; Krastev, G.; Smíšek, M.; Belan, V.
Source: Self-asserted source
Georgi Krastev via Scopus - Elsevier
How many people are using ORCID?